Costs of Hepatitis C
Open Access
- 8 October 2001
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 161 (18) , 2231-2237
- https://doi.org/10.1001/archinte.161.18.2231
Abstract
THE HEPATITIS C virus (HCV) was identified in 1988 and has received increasing attention from physicians and researchers ever since. Because HCV has only been recently identified, national statistics are difficult to obtain. Initial estimates suggested that the annual mortality due to chronic liver disease (CLD) from HCV was between 8000 and 10 000.1 Recent work2 has assumed 8000 to be the more reasonable estimate. An initial estimate of the prevalence of HCV based on the anti-HCV antibody was 3.9 million persons.3 However, more recently, Alter et al4 estimate the prevalence of active HCV infection at 2.7 million persons. Whereas the incidence of the disease has been decreasing, the overall prevalence is large, roughly 4 times as large as that of the human immunodeficiency virus.5 Sixty-five percent of persons with an HCV infection are aged 30 to 49 years. The highest rates of new infections are among persons aged 20 to 39 years.6 It is the single most common reason for liver transplantations in the United States.5 Risk factors include sharing of contaminated needles by drug users, multiple sex partners, employment as a health care worker, receipt of a blood transfusion any time before 1988, and, more generally, poverty, low educational attainment, and having been divorced or separated.4This publication has 12 references indexed in Scilit:
- Natural history of hepatitis CThe American Journal of Medicine, 1999
- Cost-effectiveness of treatments for chronic hepatitis CThe American Journal of Medicine, 1999
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- Understanding resource use in liver transplantation.JAMA, 1999
- Resource Utilization in Liver TransplantationEffects of Patient Characteristics and Clinical PracticeJAMA, 1999
- A National Estimate of the Economic Costs of AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Incidence of primary liver cancer and aetiological aspects: a study of a defined population from a low-endemicity areaBritish Journal of Cancer, 1996
- Special article the economic cost and social and psychological impact of musculoskeletal conditionsArthritis & Rheumatism, 1995
- Inside the Black Box of Administrative CostsHealth Affairs, 1992
- Cost of injury in the United States: A report to CongressPublished by American Psychological Association (APA) ,1989